English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Genzyme Corporation
Carol Ostrow
| Sep 23, 2017
Study shows Dupixent reduces symptoms of atopic dermatitis
Carol Ostrow
| Sep 20, 2017
Sanofi partner Alnylam to suspend fitusiran trial for treating hemophilia
Nicholas Gueguen
| Aug 4, 2017
Sanofi Genzyme observes Rare Disease Day globally
Ruth de Jauregui
| May 7, 2017
Data from multiple sclerosis medication study shows promise
Ruth de Jauregui
| May 7, 2017
Sanfoli Genzyme releases 6 years of data on Lemtrada in patients with relapsing remitting multiple sclerosis
Ruth de Jauregui
| May 7, 2017
Survey finds majority of rheumatoid arthritis patients living in pain
Ruth de Jauregui
| Mar 29, 2017
Multiple Myeloma Journey Partners Program to expand
Robert Lawson
| Feb 19, 2017
Trial focuses on common genetic link to Parkinson's
Trending
Patient Daily
| Aug 1, 2025
Executive director of ASAP 340B: ‘The second largest drug discount program in the country doesn't have basic transparency’
Patient Daily
| Aug 4, 2025
Founder of ReKlaim Health on 340B: ‘They pocket the difference, bill insurers and patients full price and call it charity care’
+
Pharmaceuticals
Patient Daily
| Aug 5, 2025
American Lung Association study urges schools to prioritize clean classroom air
Patient Daily
| Aug 7, 2025
Dallas Breathe Free Sinus & Allergy Centers earns 4.8-star rating from 670 Google reviews
